Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Stomach Neoplasms 2Liver Neoplasms 2Weight Loss 1Primary Graft Dysfunction 1Peripheral Nervous System Diseases 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Muscular Atrophy 1Lymphoma, Non-Hodgkin 1Liver Failure, Acute 1Liver Failure 1Liver Diseases 1Hodgkin Disease 1Hearing Loss 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Bronchogenic 1

Interventions

halofantrine 1N-monoacetylcystine 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Primary Graft Dysfunction × Acetylcysteine × Gastrointestinal × Clear all
NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Azienda Ospedaliera di Padova

Phase 2 Completed
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡